Michele Celle-Boisdron

Angers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Thymine as potential biomarker to predict 5-FU systemic exposure in patients with gastro-intestinal cancer: a prospective pharmacokinetic study (FUUT-trial).

Thymine as potential biomarker to predict 5-FU systemic exposure in patients with gastro-intestinal cancer: a prospective pharmacokinetic study (FUUT-trial).

Journal: Cancer chemotherapy and pharmacology

Published: October 31, 2024

COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19).

COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19).

Journal: Cancers

Published: September 23, 2022

COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19).

COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19).

Journal: Clinical Medicine Insights. Oncology

Published: December 14, 2021

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study.

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study.

Journal: Cancers

Published: May 25, 2021

BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report.

BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report.

Journal: Case reports in oncology

Published: May 02, 2019

In reply.

In reply.

Journal: Seminars in oncology

Published: September 20, 2017

Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach.

Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach.

Journal: Seminars in oncology

Published: April 12, 2017

A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification.

A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification.

Journal: Seminars in oncology

Published: April 12, 2017

In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps.

In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps.

Journal: Neuromodulation : journal of the International Neuromodulation Society

Published: July 01, 2013

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

Journal: mAbs

Published: June 12, 2013

Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept study.

Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept study.

Journal: Clinical colorectal cancer

Published: February 12, 2012

Biological diagnosis of resistance to erlotinib in a malignant pleural effusion

Biological diagnosis of resistance to erlotinib in a malignant pleural effusion

Journal: Revue des maladies respiratoires

Published: December 12, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026